XFLH Capital Corporation focuses on a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in Dover Delaware.…
XFLH Capital Corporation Announces the Signing of a Letter of Intent with Renogen Biolab Inc.
XFLH Capital (NYSE: XFLH) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Shell Companies industry, part of the Financial Services sector.
The shares were at 10.18 USD on 20 November 2026. Its 52-week range is 9.700 USD to 10.88 USD: the price is 6.4% below the high and 4.9% above the low.
Its market capitalisation is 146.47M USD.
XFLH Capital reports an operating margin of 0.0%.
It holds more cash than debt, a net cash position of 246.74K USD.
No upcoming events tracked.